Monte Rosa Therapeutics, Inc. (GLUE)
23.99
+0.27
(+1.14%)
USD |
NASDAQ |
Jan 13, 16:00
24.01
+0.02
(+0.08%)
After-Hours: 06:01
Monte Rosa Therapeutics Shareholders Equity (Quarterly): 245.84M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| CorMedix, Inc. | 374.13M |
| Indivior PLC | -207.00M |
| Mirum Pharmaceuticals, Inc. | 292.05M |
| Innovative Eyewear, Inc. | 10.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 459.84M |
| Total Liabilities (Quarterly) | 214.00M |
| Debt to Equity Ratio | 0.1634 |
| Current Ratio | 6.540 |
| Net Debt Paydown Yield | 0.18% |